Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Controlled Trial Evaluating the Benefits of Early Up-Front-loaded High Dose Tirofiban in the Treatment of Patients with ST-segment Elevation Myocardial Infarction, who are Candidates for Primary Angioplasty

Next Previous
X
Search
Trial Profile

A Randomized, Controlled Trial Evaluating the Benefits of Early Up-Front-loaded High Dose Tirofiban in the Treatment of Patients with ST-segment Elevation Myocardial Infarction, who are Candidates for Primary Angioplasty

Status: Completed
Phase of Trial: Phase II/III

Latest Information Update: 01 Aug 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tirofiban (Primary) ; Aspirin; Clopidogrel; Heparin
  • Indications Embolism and thrombosis; Myocardial infarction
  • Focus Pharmacodynamics; Registrational
  • Acronyms On-TIME-2

    • Most Recent Events

    • 05 Jul 2017 Results of post hoc subgroup analysis (n=918, patients with samples for NT-proBNP) published in the Heart
    • 07 Jul 2016 Results of pooled analysis from an open label phase and a double blind phase of the study, published in a Medicure media release.
    • 07 Jul 2016 According to Medicure media release, the company has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for its supplemental New Drug Application (sNDA) communicating that its initial review of the application is complete; however, it cannot approve the application in its present form and requested additional information.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top